Skip to content

Nurix Therapeutics

US · NRIX #2679 by market cap Listed 2020
12.85 -0.75 -5.51%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Recent news

  • Rating change
    RBC Capital Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Raises Target Price to $36
    Market Newswire · 2026/8/10
  • Rating change
    Wells Fargo Maintains Nurix Therapeutics(NRIX.US) With Hold Rating, Maintains Target Price $25
    Market Newswire · 2026/7/14
  • Rating change
    Baird Initiates Nurix Therapeutics(NRIX.US) With Buy Rating, Announces Target Price $36
    Market Newswire · 2026/10/13
  • Rating change
    Oppenheimer Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Raises Target Price to $32
    Market Newswire · 2026/10/13
  • Rating change
    Oppenheimer Initiates Nurix Therapeutics(NRIX.US) With Buy Rating, Announces Target Price $28
    Market Newswire · 2026/6/29
  • Piper Sandler Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Maintains Target Price $35
    Market Newswire · 2026/11/2
  • Stifel Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Maintains Target Price $41
    Market Newswire · 2026/11/5
  • Rating change
    Morgan Stanley Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Raises Target Price to $38
    Market Newswire · 2026/7/28
  • Rating change
    H.C. Wainwright Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Raises Target Price to $36
    Market Newswire · 2026/10/16
  • Rating change
    A Quick Look at Today's Ratings for Nurix Therapeutics(NRIX.US), With a Forecast Between $32 to $41
    Market Newswire · 2026/10/13
  • Rating change
    Morgan Stanley Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Maintains Target Price $38
    Market Newswire · 2026/10/15
  • Rating change
    Mizuho Securities Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Raises Target Price to $34
    Market Newswire · 2026/7/13
  • Rating change
    UBS Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Raises Target Price to $31
    Market Newswire · 2026/7/22
  • Rating change
    Jefferies Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Maintains Target Price $45
    Market Newswire · 2026/7/8
  • Rating change
    Needham Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Maintains Target Price $34
    Market Newswire · 2026/8/4
  • H.C. Wainwright Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Maintains Target Price $36
    Market Newswire · 2026/11/5
  • Rating change
    Truist Financial Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Cuts Target Price to $33
    Market Newswire · 2026/10/13
  • BTIG Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Maintains Target Price $32
    Market Newswire · 2026/11/4
  • Rating change
    A Quick Look at Today's Ratings for Nurix Therapeutics(NRIX.US), With a Forecast Between $28 to $40
    Market Newswire · 2026/7/11
  • Following Cathie Wood’s strategy: increase holdings in NRIX and SPCX, and reduce positions in PSNL and BLSH.
    牛牛名人追蹤 · 2026/11/5
  • Rating change
    H.C. Wainwright Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Maintains Target Price $32
    Market Newswire · 2026/6/11
  • Rating change
    J.P. Morgan Maintains Nurix Therapeutics(NRIX.US) With Buy Rating
    Market Newswire · 2026/6/12
  • Rating change
    Stifel Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Maintains Target Price $34
    Market Newswire · 2026/6/15
  • Rating change
    BTIG Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Maintains Target Price $32
    Market Newswire · 2026/7/1
  • Rating change
    A Quick Look at Today's Ratings for Nurix Therapeutics(NRIX.US), With a Forecast Between $25 to $32
    Market Newswire · 2026/6/10

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Nurix Therapeutics discussion 0 comments

Add a comment